Literature DB >> 19701974

Prognostic impact of dissected lymph node count on patients with node-negative gastric cancer.

Chang-Ming Huang1, Jian-Xian Lin, Chao-Hui Zheng, Ping Li, Jian-Wei Xie, Bi-Juan Lin, Hui-Shan Lu.   

Abstract

AIM: To investigate the long-term effect of the number of resected lymph nodes (LNs) on the prognosis of patients with node-negative gastric cancer.
METHODS: Clinical data of 211 patients with gastric cancer, without nodal involvement, were analyzed retrospectively after D2 radical operation. We analyzed the relationship between the number of resected LNs with the 5-year survival, the recurrence rate and the post-operative complication rate.
RESULTS: The 5-year survival of the entire cohort was 82.2%. The total number of dissected LNs was one of the independent prognostic factors. Among patients with comparable depth of invasion, the larger the number of resected LNs, the better the survival (P < 0.05). A cut-point analysis provided the possibility to detect a significant survival difference among subgroups. Patients had a better long-term survival outcomes with LN counts > or = 15 for pT1-2, > or = 20 for pT3-4, and > or = 15 for the entire cohort. The overall recurrence rate was 29.4% within 5 years after surgery. There was a statistically significant, negative correlation between the number of resected LNs and the recurrence rate (P < 0.01). The post-operative complication rate was 10.9% and was not significantly correlated with the number of dissected LNs (P > 0.05).
CONCLUSION: For node-negative gastric cancer, sufficient number of dissected LNs is recommended during D2 lymphadenectomy, to improve the long-term survival and reduce the recurrence. Suitable increments of the dissected LN count would not increase the post-operative complication rate.

Entities:  

Mesh:

Year:  2009        PMID: 19701974      PMCID: PMC2731256          DOI: 10.3748/wjg.15.3926

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

1.  Detection and prognosis of recurrent gastric cancer--is routine follow-up after gastrectomy worthwhile?

Authors:  H Böhner; T Zimmer; W Hopfenmüller; G Berger; H J Buhr
Journal:  Hepatogastroenterology       Date:  2000 Sep-Oct

2.  Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage.

Authors:  Roderich E Schwarz; David D Smith
Journal:  Ann Surg Oncol       Date:  2006-11-09       Impact factor: 5.344

3.  Solitary lymph node metastasis in gastric cancer.

Authors:  Chen Li; Sungsoo Kim; Ji Fu Lai; Sung Jin Oh; Woo Jin Hyung; Won Hyuk Choi; Seung Ho Choi; Sung Hoon Noh
Journal:  J Gastrointest Surg       Date:  2007-09-05       Impact factor: 3.452

4.  Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study.

Authors:  Franco Roviello; Daniele Marrelli; Paolo Morgagni; Giovanni de Manzoni; Alberto Di Leo; Carla Vindigni; Luca Saragoni; Anna Tomezzoli; Hayato Kurihara
Journal:  Ann Surg Oncol       Date:  2002-11       Impact factor: 5.344

5.  Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer.

Authors:  Jin-Pok Kim; Joo-Ho Lee; Soo-Jin Kim; Hang-Jong Yu; Han-Kwang Yang
Journal:  Gastric Cancer       Date:  1998-03       Impact factor: 7.370

6.  An evaluation of the effectiveness of extended lymph node dissection in patients with gastric cancer: a retrospective study of 1403 cases at a single institution.

Authors:  Yuichi Kasakura; Fumiro Mochizuki; Kazuhiko Wakabayashi; Mitsugu Kochi; Masashi Fujii; Tadatoshi Takayama
Journal:  J Surg Res       Date:  2002-04       Impact factor: 2.192

7.  Clinicopathologic characteristics and outcome indicators in node-negative gastric cancer.

Authors:  L Bruno; G Nesi; F Montinaro; G Carassale; V Boddi; P Bechi; C Cortesini
Journal:  J Surg Oncol       Date:  2000-05       Impact factor: 3.454

8.  Evaluation of the New International Union Against Cancer TNM staging for gastric carcinoma.

Authors:  H Katai; K Yoshimura; K Maruyama; M Sasako; T Sano
Journal:  Cancer       Date:  2000-04-15       Impact factor: 6.860

9.  Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.

Authors:  A Cuschieri; S Weeden; J Fielding; J Bancewicz; J Craven; V Joypaul; M Sydes; P Fayers
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

10.  Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer.

Authors:  M Degiuli; M Sasako; A Ponti; F Calvo
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640

View more
  10 in total

1.  Effects of extended lymphadenectomy and postoperative chemotherapy on node-negative gastric cancer.

Authors:  Qiang Xue; Xiao-Na Wang; Jing-Yu Deng; Ru-Peng Zhang; Han Liang
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

2.  Predictive factors for survival and recurrence rate in patients with node-negative gastric cancer--a European single-centre experience.

Authors:  Yves Dittmar; Silke Schüle; Alexander Koch; Falk Rauchfuss; Hubert Scheuerlein; Utz Settmacher
Journal:  Langenbecks Arch Surg       Date:  2014-07-23       Impact factor: 3.445

Review 3.  Management strategies for locoregional recurrence in early-stage gastric cancer: retrospective analysis and comprehensive literature review.

Authors:  Ahmed Salem; Sameh Hashem; Layth Y I Mula-Hussain; Issa Mohammed; Ala'a Nour; Wael Shelpai; Faiez Daoud; Basem Morcos; Yasser Yamin; Imad Jaradat; Jamal Khader; Abdelatief Almousa
Journal:  J Gastrointest Cancer       Date:  2012-03

4.  Prognostic factors in patients with node-negative gastric cancer: a single center experience from China.

Authors:  Xiaowen Liu; Hong Cai; Yingqiang Shi; Yanong Wang
Journal:  J Gastrointest Surg       Date:  2012-04-10       Impact factor: 3.452

5.  Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined To and Extending Beyond the Pancreas.

Authors:  Claudius Conrad; Onur C Kutlu; Arvind Dasari; Jennifer A Chan; Jean-Nicolas Vauthey; David B Adams; Michael Kim; Jason B Fleming; Matthew H G Katz; Jeffrey E Lee
Journal:  J Gastrointest Surg       Date:  2016-10-06       Impact factor: 3.452

6.  Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer.

Authors:  Xu-Guang Jiao; Jing-Yu Deng; Ru-Peng Zhang; Liang-Liang Wu; Li Wang; Hong-Gen Liu; Xi-Shan Hao; Han Liang
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

7.  Prognostic Value of the Number of Lymph Nodes Examined in Patients with Node-Negative Gastric Cancer.

Authors:  Ze-Long Yang; Ming-Hua Zhu; Quan Shi; Fu-Min Lu; Chun-Xi Wang
Journal:  J Gastrointest Surg       Date:  2018-09-17       Impact factor: 3.452

8.  Prognostic factors in patients with node-negative gastric cancer: an Indian experience.

Authors:  Ramakrishnan A Seshadri; Sunil B Jayanand; Rama Ranganathan
Journal:  World J Surg Oncol       Date:  2011-05-10       Impact factor: 2.754

9.  Metastatic lymph node ratio can further stratify risk for mortality in medullary thyroid cancer patients: A population-based analysis.

Authors:  Ning Qu; Rong-Liang Shi; Zhong-Wu Lu; Tian Liao; Duo Wen; Guo-Hua Sun; Duan-Shu Li; Qing-Hai Ji
Journal:  Oncotarget       Date:  2016-10-04

10.  Impact of the number of examined lymph nodes on stage migration in node-negative gastric cancer patients: a Chinese multi-institutional analysis with propensity score matching.

Authors:  Pengfei Gu; Jingyu Deng; Wei Wang; Zhenning Wang; Zhiwei Zhou; Huimian Xu; Han Liang
Journal:  Ann Transl Med       Date:  2020-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.